The FDA has approved phentermine and topiramate extended-release tablets (Qsymia, Vivus Inc.) for chronic weight management when used in addition to a reduced-calorie diet and exercise. The drug is indicated for use in obese or overweight adults who have at least one weight-related condition (eg, hypertension, type 2 diabetes, or dyslipidemia).
Source: FDA.
